2006
DOI: 10.1038/ng1871
|View full text |Cite
|
Sign up to set email alerts
|

CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration

Abstract: In developed countries, age-related macular degeneration is a common cause of blindness in the elderly. A common polymorphism, encoding the sequence variation Y402H in complement factor H (CFH), has been strongly associated with disease susceptibility. Here, we examined 84 polymorphisms in and around CFH in 726 affected individuals (including 544 unrelated individuals) and 268 unrelated controls. In this sample, 20 of these polymorphisms showed stronger association with disease susceptibility than the Y402H va… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
237
0
6

Year Published

2007
2007
2012
2012

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 310 publications
(255 citation statements)
references
References 28 publications
12
237
0
6
Order By: Relevance
“…In addition, analyses of human blood for indicators of inflammation, such as C-reactive protein and white blood cell count, showed associations of inflammation with AMD (Seddon et al, 2004;Despriet et al, 2006;Shankar et al, 2007). Finally, a common polymorphism in the complement regulatory protein, complement factor H (CFH) (Tyr402His), was found to be strongly associated with increased risk of AMD, providing further evidence supporting inflammation in AMD (Klein et al, 2005;Maller et al, 2006;Li et al, 2006b;Haines et al, 2005;Edwards et al, 2005;Rivera et al, 2005).…”
Section: Stimuli For Neovascular Amd and Vegf Expressionmentioning
confidence: 86%
See 1 more Smart Citation
“…In addition, analyses of human blood for indicators of inflammation, such as C-reactive protein and white blood cell count, showed associations of inflammation with AMD (Seddon et al, 2004;Despriet et al, 2006;Shankar et al, 2007). Finally, a common polymorphism in the complement regulatory protein, complement factor H (CFH) (Tyr402His), was found to be strongly associated with increased risk of AMD, providing further evidence supporting inflammation in AMD (Klein et al, 2005;Maller et al, 2006;Li et al, 2006b;Haines et al, 2005;Edwards et al, 2005;Rivera et al, 2005).…”
Section: Stimuli For Neovascular Amd and Vegf Expressionmentioning
confidence: 86%
“…AMD develops late in life, yet is strongly associated with certain common genetic mutations (Klein et al, 2005;Maller et al, 2006;Li et al, 2006b;Haines et al, 2005;Edwards et al, 2005;Rivera et al, 2005). Evidence supports that both genetic and environmental factors play a role in the pathogenesis (Seddon et al, 2006b).…”
Section: Amd Overviewmentioning
confidence: 99%
“…It is unknown whether rs2326398, which is not a splice site or in a coding region, might cause a functional change in the protein (43,44). Intronic SNPs have been shown to be associated with other complex diseases, such as IRF6 with NSCLP, RET (RET proto-oncogene) with Hirschsprung disease and CFH (complement factor H) with age-related macular degeneration (13,14,16,(45)(46)(47). Together, this suggests that common genetic variation in non-coding regions may be important and should not be overlooked in complex human diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Recent progress in AMD genetics has established several important risk loci, among them the complement factor H (CFH) on chromosome 1 (1q31) (Edwards et al 2005;Hageman et al 2005Hageman et al , 2006Hughes et al 2006;Klein et al 2005;Li et al 2006) and the age-related maculopathy susceptibility 2 (ARMS2/HTRA1) on chromosome 10 (10q26) (Dewan et al 2006;Jakobsdottir et al 2005;Rivera et al 2005;Schmidt et al 2006;Tanimoto et al 2007;Weger et al 2007;Yang et al 2006). Both loci combined are thought to account for more than 50 % of AMD cases (Edwards et al 2005;Klein et al 2005;Maller et al 2006;Swaroop et al 2007;Thakkinstian et al 2006).…”
Section: Introductionmentioning
confidence: 99%